Otonomy (Otonomy) 3-Year Book Growth Rate : 0.00% (As of Sep. 2022)

View and export this data going back to 2014. Start your Free Trial

What is Otonomy 3-Year Book Growth Rate?

Otonomy's Book Value per Share for the quarter that ended in Sep. 2022 was $0.38.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Competitive Comparison of Otonomy's 3-Year Book Growth Rate

For the Biotechnology subindustry, Otonomy's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Otonomy's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Otonomy's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Otonomy's 3-Year Book Growth Rate falls into.

Otonomy 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Otonomy (OTCPK:OTIC) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Otonomy 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Otonomy's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Otonomy (Otonomy) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Otonomy Inc (OTCPK:OTIC) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

4796 Executive Drive, San Diego, CA, USA, 92121

Website

https://www.otonomy.com

Otonomy Inc is a biopharmaceutical company, focuses on the development and commercialization of therapeutics for diseases and disorders of the ear. It offers OTIPRIO, a ciprofloxacin otic suspension for use during tympanostomy tube placement surgery in pediatric patients. The company also develops OTO-104, a sustained-exposure formulation of the steroid dexamethasone for the treatment of Meniere's disease and other inner ear conditions; and OTO-311, a sustained-exposure formulation for the treatment of tinnitus. All the business activity primarily operates through the region of the United States.

Executives

Hogan H Michael Iii	director	C/O 3D SYSTEMS, 26081 AVENUE HALL, VALENCIA CA 91355
Vickie L Capps	director	2985 SCOTT STREET, VISTA CA 92083
Alan Charles Foster	officer: Chief Scientific Officer	4796 EXECUTIVE DRIVE, SAN DIEGO CA 92121
Savel Robert Michael Ii	officer: Chief Technical Officer	1025 OPAL WAY, VACAVILLE CA 95687
Paul E Cayer	officer: CFO/Ch. Business Offcr & Sec.	C/O OTONOMY, INC., 6275 NANCY RIDGE ROAD, SUITE 100, SAN DIEGO CA 92121
David Allen Weber	director, officer: President & CEO	C/O OTONOMY, INC., 6275 NANCY RIDGE ROAD, SUITE 100, SAN DIEGO CA 92121
Jill Marie Broadfoot	director	3545 JOHN HOPKINS COURT, SUITE 250, SAN DIEGO CA 92121
Jay Lichter	director	C/O ARATANA THERAPEUTICS, INC., 11400 TOMAHAWK CREEK PARKWAY, SUITE 340, LEAWOOD KS 66211
Ciara Kennedy	director	C/O LUMENA PHARMACEUTICALS, INC., 12531 HIGH BLUFF DRIVE, SUITE 110, SAN DIEGO CA 92130
James B Breitmeyer	director
Eric J Loumeau	officer: GC & Chief Compliance Officer	C/O HOLLIS-EDEN PHARMACEUTICALS, 4435 EASTGATE MALL STE.400, SAN DIEGO CA 92121
Katherine Mary Bishop	officer: Chief Scientific Officer	C/O OTONOMY, INC., 4796 EXECUTIVE DRIVE, SAN DIEGO CA 92121
Carl Lebel	officer: Chief Scientific Officer	23256 MARIPOSA DE ORO, MALIBU CA 90265
Iain Mcgill	director	C/O JAZZ PHARMACEUTICALS PLC, 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN L2 4 L2
Chau Quang Khuong	director	C/O ORBIMED ADVISORS, 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022